{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:41:03Z","timestamp":1784234463764,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shandong Medical and Health Technology Development Plan","award":["2019WS529"],"award-info":[{"award-number":["2019WS529"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02455-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T15:13:08Z","timestamp":1769008388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GTS-21 Alleviates Acute Lung Injury by Enhancing GLP-1 Secretion and Regulating Alveolar Surfactant Proteins via \u03b17nAChR Activation"],"prefix":"10.1007","volume":"49","author":[{"given":"Chunli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkun","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niitiggya","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghe","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"issue":"10300","key":"2455_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","volume":"398","author":"NJ Meyer","year":"2021","unstructured":"Meyer, N.J., L. Gattinoni, and C.S. Calfee. 2021. Acute respiratory distress syndrome. Lancet (London, England) 398 (10300): 622\u2013637. https:\/\/doi.org\/10.1016\/S0140-6736(21)00439-6.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2455_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0069-0","volume":"5","author":"MA Matthay","year":"2019","unstructured":"Matthay, M.A., R.L. Zemans, G.A. Zimmerman, et al. 2019. Acute respiratory distress syndrome. Nature Reviews. Disease Primers 5 (1): 18. https:\/\/doi.org\/10.1038\/s41572-019-0069-0.","journal-title":"Nature Reviews. Disease Primers"},{"key":"2455_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.922702","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu, C., K. Xiao, and L. Xie. 2022. Progress in preclinical studies of macrophage autophagy in the regulation of ALI\/ARDS. Frontiers in Immunology 13: 922702. https:\/\/doi.org\/10.3389\/fimmu.2022.922702.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2455_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.151950","volume":"225","author":"S Douaoui","year":"2020","unstructured":"Douaoui, S., R. Djidjik, M. Boubakeur, et al. 2020. GTS-21, an \u03b17nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function. Immunobiology 225 (3): 151950. https:\/\/doi.org\/10.1016\/j.imbio.2020.151950.","journal-title":"Immunobiology"},{"key":"2455_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106306","volume":"82","author":"M Mashimo","year":"2020","unstructured":"Mashimo, M., T. Fujii, S. Ono, Y. Moriwaki, H. Misawa, and K. Kawashima. 2020. Minireview: Divergent roles of \u03b17 nicotinic acetylcholine receptors expressed on antigen-presenting cells and CD4 T cells in the regulation of T cell differentiation+. International Immunopharmacology 82: 106306. https:\/\/doi.org\/10.1016\/j.intimp.2020.106306.","journal-title":"International Immunopharmacology"},{"key":"2455_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111603","volume":"129","author":"W Zhu","year":"2024","unstructured":"Zhu, W., F. Wang, C. Hu, et al. 2024. GTS-21 attenuates ACE\/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17. International Immunopharmacology 129: 111603. https:\/\/doi.org\/10.1016\/j.intimp.2024.111603.","journal-title":"International Immunopharmacology"},{"issue":"8","key":"2455_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/j.ymthe.2024.05.037","volume":"32","author":"C Zhao","year":"2024","unstructured":"Zhao, C., J. Chen, Z. Liu, et al. 2024. Activation of nicotinic acetylcholine receptor \u03b17 subunit limits Zika viral infection via promoting autophagy and ferroptosis. Molecular Therapy 32 (8): 2641\u20132661. https:\/\/doi.org\/10.1016\/j.ymthe.2024.05.037.","journal-title":"Molecular Therapy"},{"key":"2455_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112555","volume":"138","author":"A Yang","year":"2024","unstructured":"Yang, A., C.H. Wu, S. Matsuo, R. Umene, Y. Nakamura, and T. Inoue. 2024. Activation of the \u03b17nAChR by GTS-21 mitigates septic tubular cell injury and modulates macrophage infiltration. International Immunopharmacology 138: 112555. https:\/\/doi.org\/10.1016\/j.intimp.2024.112555.","journal-title":"International Immunopharmacology"},{"key":"2455_CR9","doi-asserted-by":"publisher","unstructured":"Li, R., X. Hu, and H. Chen et al. 2022. Role of Cholinergic Anti-Inflammatory Pathway in Protecting Sepsis-Induced Acute Lung Injury through Regulation of the Conventional Dendritic Cells. Reale M, ed. Mediators Inflamm. 2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/1474891","DOI":"10.1155\/2022\/1474891"},{"issue":"5","key":"2455_CR10","doi-asserted-by":"publisher","first-page":"F540","DOI":"10.1152\/ajprenal.00334.2021","volume":"322","author":"D Goto","year":"2022","unstructured":"Goto, D., S. Nagata, Y. Naito, et al. 2022. Nicotinic acetylcholine receptor agonist reduces acute lung injury after renal ischemia-reperfusion injury by acting on splenic macrophages in mice. American Journal of Physiology-Renal Physiology 322 (5): F540\u2013F552. https:\/\/doi.org\/10.1152\/ajprenal.00334.2021.","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"2455_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111603IF","volume":"129","author":"W Zhu","year":"2024","unstructured":"Zhu, W., F. Wang, C. Hu, Q. Zhao, D. Zhang, X. Wang, B. Hu, and J. Li. 2024. GTS-21 attenuates ACE\/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17. International Immunopharmacology 129: 111603. https:\/\/doi.org\/10.1016\/j.intimp.2024.111603IF.","journal-title":"International Immunopharmacology"},{"issue":"3","key":"2455_CR12","doi-asserted-by":"publisher","first-page":"L368","DOI":"10.1152\/ajplung.00041.2023","volume":"325","author":"B Baer","year":"2023","unstructured":"Baer, B., N.D. Putz, K. Riedmann, et al. 2023. Liraglutide pretreatment attenuates sepsis-induced acute lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology 325 (3): L368\u2013L384. https:\/\/doi.org\/10.1152\/ajplung.00041.2023.","journal-title":"American Journal of Physiology-Lung Cellular and Molecular Physiology"},{"issue":"4","key":"2455_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","volume":"99","author":"J Xu","year":"2019","unstructured":"Xu, J., G. Wei, J. Wang, et al. 2019. Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function. Laboratory Investigation 99 (4): 577\u2013587. https:\/\/doi.org\/10.1038\/s41374-018-0170-0.","journal-title":"Laboratory Investigation"},{"issue":"3","key":"2455_CR14","doi-asserted-by":"publisher","first-page":"E568","DOI":"10.1152\/ajpendo.00292.2020","volume":"319","author":"W Zhou","year":"2020","unstructured":"Zhou, W., W. Shao, Y. Zhang, D. Liu, M. Liu, and T. Jin. 2020. Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein. American Journal of Physiology-Endocrinology and Metabolism 319 (3): E568\u2013E578. https:\/\/doi.org\/10.1152\/ajpendo.00292.2020.","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"3","key":"2455_CR15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s11095-010-0322-4","volume":"28","author":"SB Lim","year":"2011","unstructured":"Lim, S.B., I. Rubinstein, R.T. Sadikot, J.E. Artwohl, and H. \u00d6ny\u00fcksel. 2011. A novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles. Pharmaceutical Research 28 (3): 662\u2013672. https:\/\/doi.org\/10.1007\/s11095-010-0322-4.","journal-title":"Pharmaceutical Research"},{"key":"2455_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1964955","author":"S Sazgarnejad","year":"2022","unstructured":"Sazgarnejad, S., N. Yazdanpanah, and N. Rezaei. 2022. Anti-inflammatory effects of GLP-1 in patients with COVID-19. Expert Review of Anti-Infective Therapy. https:\/\/doi.org\/10.1080\/14787210.2021.1964955.","journal-title":"Expert Review of Anti-Infective Therapy"},{"issue":"4","key":"2455_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167726","volume":"1871","author":"Q Meng","year":"2025","unstructured":"Meng, Q., I. Jacob, C. Wang, et al. 2025. Pathogenesis and therapeutic effect of sitagliptin in experimental diabetic model of COVID-19. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1871 (4): 167726. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167726.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"2455_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109031","volume":"179","author":"TI Hariyanto","year":"2021","unstructured":"Hariyanto, T.I., D. Intan, J.E. Hananto, C. Putri, and A. Kurniawan. 2021. Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression. Diabetes Research and Clinical Practice 179: 109031. https:\/\/doi.org\/10.1016\/j.diabres.2021.109031.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"8","key":"2455_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11082292","volume":"11","author":"S Greco","year":"2023","unstructured":"Greco, S., V.M. Monda, G. Valpiani, et al. 2023. The impact of GLP-1 RAs and DPP-4is on hospitalisation and mortality in the COVID-19 era: A two-year observational study. Biomedicines 11 (8): 2292. https:\/\/doi.org\/10.3390\/biomedicines11082292.","journal-title":"Biomedicines"},{"issue":"4","key":"2455_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SHK.0000000000002285","volume":"61","author":"J Guo","year":"2024","unstructured":"Guo, J., X. Chen, C. Wang, et al. 2024. Liraglutide alleviates acute lung injury and mortality in pneumonia-induced sepsis through regulating surfactant protein expression and secretion. Shock 61 (4): 601\u2013610. https:\/\/doi.org\/10.1097\/SHK.0000000000002285.","journal-title":"Shock"},{"key":"2455_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1203389","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang, J., X. Ma, F. Liu, et al. 2023. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention. Frontiers in Immunology 14: 1203389. https:\/\/doi.org\/10.3389\/fimmu.2023.1203389.","journal-title":"Frontiers in Immunology"},{"issue":"21","key":"2455_CR22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI194751","volume":"135","author":"CK Wong","year":"2025","unstructured":"Wong, C.K., and D.J. Drucker. 2025. Antiinflammatory actions of glucagon-like peptide-1\u2013based therapies beyond metabolic benefits. Journal of Clinical Investigation 135 (21): e194751. https:\/\/doi.org\/10.1172\/JCI194751.","journal-title":"Journal of Clinical Investigation"},{"issue":"11","key":"2455_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/thorax.58.11.983","volume":"58","author":"M Eisner","year":"2003","unstructured":"Eisner, M., P. Parsons, M. Matthay, L. Ware, and K. Greene. 2003. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 58(11):983\u2013988. https:\/\/doi.org\/10.1136\/thorax.58.11.983","journal-title":"Thorax"},{"key":"2455_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1188023","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X., J. Guo, S. Mahmoud, et al. 2023. Regulatory roles of SP-A and exosomes in pneumonia-induced acute lung and kidney injuries. Frontiers in Immunology 14: 1188023. https:\/\/doi.org\/10.3389\/fimmu.2023.1188023.","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"2455_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1080\/08923973.2024.2384897","volume":"46","author":"J Guo","year":"2024","unstructured":"Guo, J., X. Zhang, R. Pan, Y. Zheng, W. Chen, and L. Wang. 2024. Liraglutide alleviates sepsis-induced acute lung injury by regulating pulmonary surfactant through inhibiting autophagy. Immunopharmacology and Immunotoxicology 46 (5): 573\u2013582. https:\/\/doi.org\/10.1080\/08923973.2024.2384897.","journal-title":"Immunopharmacology and Immunotoxicology"},{"issue":"10","key":"2455_CR26","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1210\/en.2014-1685","volume":"156","author":"M Roman\u00ed-P\u00e9rez","year":"2015","unstructured":"Roman\u00ed-P\u00e9rez, M., V. Outeiri\u00f1o-Iglesias, C.M. Moya, et al. 2015. Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology 156 (10): 3559\u20133569. https:\/\/doi.org\/10.1210\/en.2014-1685.","journal-title":"Endocrinology"},{"key":"2455_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3601454","volume":"2018","author":"T Zhu","year":"2018","unstructured":"Zhu, T., C. Li, X. Zhang, et al. 2018. GLP-1 analogue liraglutide enhances SP-A expression in LPS-induced acute lung injury through the TTF-1 signaling pathway. Mediators of Inflammation 2018: 1\u201314. https:\/\/doi.org\/10.1155\/2018\/3601454.","journal-title":"Mediators of Inflammation"},{"issue":"9","key":"2455_CR28","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1210\/en.2018-00433","volume":"159","author":"D Wang","year":"2018","unstructured":"Wang, D., Q. Meng, C.A. Leech, et al. 2018. \u03b17 nicotinic acetylcholine receptor regulates the function and viability of L cells. Endocrinology 159 (9): 3132\u20133142. https:\/\/doi.org\/10.1210\/en.2018-00433.","journal-title":"Endocrinology"},{"issue":"7","key":"2455_CR29","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/dom.14693","volume":"24","author":"Q Meng","year":"2022","unstructured":"Meng, Q., O.G. Chepurny, C.A. Leech, N. Pruekprasert, M.E. Molnar, J.J. Collier, R.N. Cooney, and G.G. Holz. 2022. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db\/db mice. Diabetes, Obesity & Metabolism 24 (7): 1255\u20131266. https:\/\/doi.org\/10.1111\/dom.14693.","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"1","key":"2455_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-27015-y","volume":"12","author":"Q Meng","year":"2022","unstructured":"Meng, Q., X. Tian, J. Li, et al. 2022. GTS-21, a selective alpha7 nicotinic acetylcholine receptor agonist, ameliorates diabetic nephropathy in Leprdb\/db mice. Scientific Reports 12 (1): 22360. https:\/\/doi.org\/10.1038\/s41598-022-27015-y.","journal-title":"Scientific Reports"},{"issue":"1","key":"2455_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42665-2","volume":"13","author":"Q Meng","year":"2023","unstructured":"Meng, Q., J. Ma, L. Suo, N. Pruekprasert, P. Chakrapani, and R.N. Cooney. 2023. Galantamine improves glycemic control and diabetic nephropathy in Leprdb\/db mice. Scientific Reports 13 (1): 15544. https:\/\/doi.org\/10.1038\/s41598-023-42665-2.","journal-title":"Scientific Reports"},{"issue":"11","key":"2455_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188797","volume":"12","author":"PK Chatterjee","year":"2017","unstructured":"Chatterjee, P.K., M.M. Yeboah, M.H. Solanki, et al. 2017. Activation of the cholinergic anti-inflammatory pathway by GTS-21 attenuates cisplatin-induced acute kidney injury in mice. PLoS One 12 (11): e0188797. https:\/\/doi.org\/10.1371\/journal.pone.0188797.","journal-title":"PLoS One"},{"issue":"4","key":"2455_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/01.CCM.0000259381.56526.96","volume":"35","author":"VA Pavlov","year":"2007","unstructured":"Pavlov, V.A., M. Ochani, L.H. Yang, M. Gallowitsch-Puerta, K. Ochani, X. Lin, J. Levi, W.R. Parrish, M. Rosas-Ballina, C.J. Czura, G.J. Larosa, E.J. Miller, K.J. Tracey, and Y. Al-Abed. 2007. Selective \u03b17-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis*. Critical Care Medicine 35 (4): 1139\u20131144. https:\/\/doi.org\/10.1097\/01.CCM.0000259381.56526.96.","journal-title":"Critical Care Medicine"},{"issue":"6","key":"2455_CR34","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/SHK.0000000000001792","volume":"56","author":"N Pruekprasert","year":"2021","unstructured":"Pruekprasert, N., Q. Meng, R. Gu, et al. 2021. \u03b17 nicotinic acetylcholine receptor agonists regulate inflammation and growth hormone resistance in sepsis. Shock 56 (6): 1057\u20131065. https:\/\/doi.org\/10.1097\/SHK.0000000000001792.","journal-title":"Shock"},{"issue":"12","key":"2455_CR35","volume":"5","author":"G Ortiz-Mu\u00f1oz","year":"2015","unstructured":"Ortiz-Mu\u00f1oz, G., and M.R. Looney. 2015. Non-invasive intratracheal instillation in mice. Bio-protocol 5 (12): e1504.","journal-title":"Bio-protocol"},{"issue":"5","key":"2455_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1097\/SHK.0000000000001927","volume":"57","author":"Q Meng","year":"2022","unstructured":"Meng, Q., X. Wang, D. Guo, et al. 2022. Nano-chemically modified Tetracycline-3 (nCMT-3) attenuates acute lung injury via blocking sTREM-1 release and NLRP3 inflammasome activation. Shock 57 (5): 749. https:\/\/doi.org\/10.1097\/SHK.0000000000001927.","journal-title":"Shock"},{"issue":"5","key":"2455_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","volume":"44","author":"G Matute-Bello","year":"2011","unstructured":"Matute-Bello, G., G. Downey, B.B. Moore, et al. 2011. An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals. American Journal of Respiratory Cell and Molecular Biology 44 (5): 725\u2013738. https:\/\/doi.org\/10.1165\/rcmb.2009-0210ST.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"1","key":"2455_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","volume":"36","author":"CK Wong","year":"2024","unstructured":"Wong, C.K., B.A. McLean, L.L. Baggio, et al. 2024. Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metabolism 36 (1): 130-143.e5. https:\/\/doi.org\/10.1016\/j.cmet.2023.11.009.","journal-title":"Cell Metabolism"},{"issue":"4","key":"2455_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/bja\/aer202","volume":"107","author":"M Kox","year":"2011","unstructured":"Kox, M., J.C. Pompe, E. Peters, et al. 2011. \u03b17 Nicotinic acetylcholine receptor agonist GTS-21 attenuates ventilator-induced tumour necrosis factor-\u03b1 production and lung injury. British Journal of Anaesthesia 107 (4): 559\u2013566. https:\/\/doi.org\/10.1093\/bja\/aer202.","journal-title":"British Journal of Anaesthesia"},{"key":"2455_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00177-z","volume":"26","author":"RA Sitapara","year":"2020","unstructured":"Sitapara, R.A., A.G. Gauthier, S.I. Vald\u00e9s-Ferrer, et al. 2020. The \u03b17 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation. Molecular Medicine 26: 63. https:\/\/doi.org\/10.1186\/s10020-020-00177-z.","journal-title":"Molecular Medicine"},{"key":"2455_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102614","volume":"60","author":"AG Gauthier","year":"2023","unstructured":"Gauthier, A.G., M. Lin, S. Zefi, et al. 2023. GAT107-mediated \u03b17 nicotinic acetylcholine receptor signaling attenuates inflammatory lung injury and mortality in a mouse model of ventilator-associated pneumonia by alleviating macrophage mitochondrial oxidative stress via reducing MnSOD-S-glutathionylation. Redox Biology 60: 102614. https:\/\/doi.org\/10.1016\/j.redox.2023.102614.","journal-title":"Redox Biology"},{"key":"2455_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1474891","volume":"2022","author":"R Li","year":"2022","unstructured":"Li, R., X. Hu, H. Chen, et al. 2022. Role of cholinergic anti-inflammatory pathway in protecting sepsis-induced acute lung injury through regulation of the conventional dendritic cells. Mediators of Inflammation 2022: 1474891. https:\/\/doi.org\/10.1155\/2022\/1474891.","journal-title":"Mediators of Inflammation"},{"issue":"3","key":"2455_CR43","doi-asserted-by":"publisher","first-page":"L368","DOI":"10.1152\/ajplung.00041.2023","volume":"325","author":"B Baer","year":"2023","unstructured":"Baer, B., N.D. Putz, K. Riedmann, et al. 2023. Liraglutide pretreatment attenuates sepsis-induced acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 325 (3): L368\u2013L384. https:\/\/doi.org\/10.1152\/ajplung.00041.2023.","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"issue":"4","key":"2455_CR44","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41374-018-0170-0","volume":"99","author":"J Xu","year":"2019","unstructured":"Xu, J., G. Wei, J. Wang, et al. 2019. Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function. Laboratory Investigation 99 (4): 577\u2013587. https:\/\/doi.org\/10.1038\/s41374-018-0170-0.","journal-title":"Laboratory Investigation"},{"issue":"7","key":"2455_CR45","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/dom.14693","volume":"24","author":"Q Meng","year":"2022","unstructured":"Meng, Q., O.G. Chepurny, C.A. Leech, et al. 2022. The alpha-7 nicotinic acetylcholine receptor agonist GTS-21 engages the glucagon-like peptide-1 incretin hormone axis to lower levels of blood glucose in db\/db mice. Diabetes, Obesity & Metabolism 24 (7): 1255\u20131266. https:\/\/doi.org\/10.1111\/dom.14693.","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"2455_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6920620","volume":"2018","author":"J Fandi\u00f1o","year":"2018","unstructured":"Fandi\u00f1o, J., A.A. Vaz, L. Toba, et al. 2018. Liraglutide enhances the activity of the ACE-2\/Ang(1\u20137)\/Mas receptor pathway in lungs of male pups from food-restricted mothers and prevents the reduction of SP-A. International Journal of Endocrinology 2018: 6920620. https:\/\/doi.org\/10.1155\/2018\/6920620.","journal-title":"International Journal of Endocrinology"},{"key":"2455_CR47","doi-asserted-by":"crossref","unstructured":"Benito, E., E. Blazquez, and M. A. Bosch. Glucagon-Like Peptide-1-(7\u201336)Amide increases pulmonary surfactant secretion through a Cyclic adenosine 3\u2032,5\u2032-Monophosphate-Dependent protein kinase mechanism in rat type II pneumocytes. 139(5).","DOI":"10.1210\/endo.139.5.5998"},{"issue":"4","key":"2455_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1164\/ajrccm.163.4.9912132","volume":"163","author":"E Vara","year":"2001","unstructured":"Vara, E., J. Arias-D\u00edaz, C. Garcia, J.L. Balibrea, and E. Bl\u00e1zquez. 2001. Glucagon-like peptide-1(7\u201336) amide stimulates surfactant secretion in human type II pneumocytes. American Journal of Respiratory and Critical Care Medicine 163 (4): 840\u2013846. https:\/\/doi.org\/10.1164\/ajrccm.163.4.9912132.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"2455_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3601454","volume":"2018","author":"T Zhu","year":"2018","unstructured":"Zhu, T., C. Li, X. Zhang, et al. 2018. GLP-1 analogue liraglutide enhances SP-A expression in LPS-induced acute lung injury through the TTF-1 signaling pathway. Mediators of Inflammation 2018: 3601454. https:\/\/doi.org\/10.1155\/2018\/3601454.","journal-title":"Mediators of Inflammation"},{"issue":"Suppl 2","key":"2455_CR50","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.33549\/physiolres.933672","volume":"66","author":"M Kolomaznik","year":"2017","unstructured":"Kolomaznik, M., Z. Nova, and A. Calkovska. 2017. Pulmonary surfactant and bacterial lipopolysaccharide: The interaction and its functional consequences. Physiological Research 66(Suppl 2):S147\u2013S157. https:\/\/doi.org\/10.33549\/physiolres.933672","journal-title":"Physiological Research"},{"issue":"3","key":"2455_CR51","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1513\/pats.200701-018AW","volume":"4","author":"AM Pastva","year":"2007","unstructured":"Pastva, A.M., J.R. Wright, and K.L. Williams. 2007. Immunomodulatory roles of surfactant proteins A and D: Implications in lung disease. Proceedings of the American Thoracic Society 4 (3): 252\u2013257. https:\/\/doi.org\/10.1513\/pats.200701-018AW.","journal-title":"Proceedings of the American Thoracic Society"},{"key":"2455_CR52","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejphar.2016.10.016","volume":"791","author":"F Zhou","year":"2016","unstructured":"Zhou, F., Y. Zhang, J. Chen, X. Hu, and Y. Xu. 2016. Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice. European Journal of Pharmacology 791:735\u2013740. https:\/\/doi.org\/10.1016\/j.ejphar.2016.10.016","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"2455_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00224-9","volume":"26","author":"RA Sitapara","year":"2020","unstructured":"Sitapara, R.A., A.G. Gauthier, V.S. Patel, et al. 2020. GTS-21, an \u03b17nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Molecular Medicine 26 (1): 98. https:\/\/doi.org\/10.1186\/s10020-020-00224-9.","journal-title":"Molecular Medicine"},{"key":"2455_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-020-00224-9","volume":"26","author":"RA Sitapara","year":"2020","unstructured":"Sitapara, R.A., A.G. Gauthier, V.S. Patel, et al. 2020. GTS-21, an \u03b17nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function. Molecular Medicine 26: 98. https:\/\/doi.org\/10.1186\/s10020-020-00224-9.","journal-title":"Molecular Medicine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02455-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T14:11:17Z","timestamp":1770646277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02455-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2455"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02455-0","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}